Drug intelligence / Profile preview

hypertonic albumin

Development stage
Unknown
Lead developer
KM Biologics
Administration
Intravenous
01

Overview

Hypertonic albumin refers to concentrated solutions of human serum albumin, typically at concentrations of 20% or 25%, which exert significantly higher colloid osmotic pressure than standard 5% (iso-oncotic) solutions. These formulations are primarily used for rapid plasma volume expansion, the management of severe hypoalbuminemia, and the reduction of edema in conditions such as cirrhosis or nephrotic syndrome. KM Biologics is developing a specific hypertonic albumin replacement fluid, identified by the code Alb-PE-01, for use in plasma exchange (PE) therapy. This product is being investigated as a replacement fluid in patients with autoimmune and neurological conditions, including myasthenia gravis, systemic lupus erythematosus, and chronic inflammatory demyelinating polyneuropathy, to evaluate its safety profile and its ability to maintain oncotic pressure and protein levels during the exchange process.

Other names
hypertonic albumin replacement fluidconcentrated albumin

Beyond the preview

Go deeper on hypertonic albumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hypertonic albumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call